Detalhe da pesquisa
1.
FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic Mastocytosis.
Oncologist
; 23(12): 1511-1519, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30115735
2.
FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia.
Oncologist
; 23(9): 1103-1108, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29650683
3.
U.S. Food and Drug Administration approval summary: Eltrombopag for the treatment of pediatric patients with chronic immune (idiopathic) thrombocytopenia.
Pediatr Blood Cancer
; 64(12)2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28627134
4.
U.S. Food and Drug Administration approval summary: omacetaxine mepesuccinate as treatment for chronic myeloid leukemia.
Oncologist
; 19(1): 94-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24309980
5.
Some Thoughts on the Use of Predictive Probability in Clinical Trials.
Ther Innov Regul Sci
; 57(3): 464-466, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630011
6.
The influence of body size descriptors on the estimation of kidney function in normal weight, overweight, obese, and morbidly obese adults.
Ann Pharmacother
; 46(3): 317-28, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22395245
7.
A systematic comparison of cockcroft-gault and modification of diet in renal disease equations for classification of kidney dysfunction and dosage adjustment.
Ann Pharmacother
; 46(9): 1174-87, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22932303
8.
Hearing threshold levels at age 70 years (65-74 years) in the unscreened older adult population of the United States, 1959-1962 and 1999-2006.
Ear Hear
; 33(3): 437-40, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22080933
9.
Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses.
J Clin Oncol
; 40(8): 847-854, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34890212
10.
Americans hear as well or better today compared with 40 years ago: hearing threshold levels in the unscreened adult population of the United States, 1959-1962 and 1999-2004.
Ear Hear
; 31(6): 725-34, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20683190
11.
Racial disparities in stillbirth risk across gestation in the United States.
Am J Obstet Gynecol
; 201(5): 469.e1-8, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19762004
12.
Bayesian hierarchical methods for meta-analysis combining randomized-controlled and single-arm studies.
Stat Methods Med Res
; 28(5): 1293-1310, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29433407
13.
FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2.
Oncologist
; 13(10): 1114-9, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18849320
14.
Bortezomib for the treatment of mantle cell lymphoma.
Clin Cancer Res
; 13(18 Pt 1): 5291-4, 2007 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17875757
15.
FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia.
Clin Cancer Res
; 24(14): 3242-3246, 2018 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29476018
16.
Toxicity of substituted anilines to Pseudokirchneriella subcapitata and quantitative structure-activity relationship analysis for polar narcotics.
Environ Toxicol Chem
; 26(6): 1158-64, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17571680
17.
FDA Drug Approval: Elotuzumab in Combination with Lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma.
Clin Cancer Res
; 23(22): 6759-6763, 2017 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28249893
18.
Low serum micronutrient concentrations predict frailty among older women living in the community.
J Gerontol A Biol Sci Med Sci
; 61(6): 594-9, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16799142
19.
Maternal age and the risk of stillbirth throughout pregnancy in the United States.
Am J Obstet Gynecol
; 195(3): 764-70, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16949411
20.
FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease.
Clin Cancer Res
; 21(5): 950-4, 2015 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25601959